Copyright: ©Author(s) 2026.
World J Psychiatry. Jul 19, 2026; 16(7): 117251
Published online Jul 19, 2026. doi: 10.5498/wjp.117251
Published online Jul 19, 2026. doi: 10.5498/wjp.117251
Table 1 Comparison of baseline characteristics between two groups, n (%)/mean ± SD
| Parameter | Goal-directed fluid therapy group (n = 110) | Conventional fluid therapy group (n = 110) | Statistic | P value |
| General information | ||||
| Age (years) | 68.3 ± 5.7 | 67.9 ± 6.1 | t = 0.497 | 0.620 |
| Sex (male/female) | 60/50 | 58/52 | χ² = 0.074 | 0.786 |
| Male | 60 (54.5) | 58 (52.7) | ||
| Body mass index (kg/m²) | 24.2 ± 3.1 | 23.9 ± 3.3 | t = 0.684 | 0.495 |
| Years of education | 9.8 ± 3.2 | 10.1 ± 3.5 | t = 0.648 | 0.518 |
| American Society of Anesthesiologists classification | χ² = 0.385 | 0.825 | ||
| Class I | 18 (16.4) | 20 (18.2) | ||
| Class II | 67 (60.9) | 64 (58.2) | ||
| Class III | 25 (22.7) | 26 (23.6) | ||
| Medical history | ||||
| Hypertension | 52 (47.3) | 55 (50.0) | χ² = 0.162 | 0.687 |
| Diabetes mellitus | 28 (25.5) | 31 (28.2) | χ² = 0.215 | 0.643 |
| Coronary heart disease | 15 (13.6) | 18 (16.4) | χ² = 0.347 | 0.556 |
| Surgical information | ||||
| Surgical type | χ² = 0.165 | 0.685 | ||
| Abdominal surgery | 66 (60.0) | 69 (62.7) | ||
| Orthopedic surgery | 44 (40.0) | 41 (37.3) | ||
| Surgical duration (hours) | 3.2 ± 0.8 | 3.1 ± 0.9 | t = 0.856 | 0.393 |
| Anesthesia duration (hours) | 3.8 ± 0.9 | 3.7 ± 1.0 | t = 0.767 | 0.444 |
| Estimated blood loss (mL) | 385 ± 125 | 392 ± 138 | t = 0.388 | 0.698 |
| Anxiety-depression assessment | ||||
| Anxiety-depression | 45 (40.9) | 47 (42.7) | χ² = 0.071 | 0.791 |
| HADS-A scorec | ||||
| Anxiety-depression subgroup | 10.3 ± 2.0 | 10.1 ± 2.2 | t = 0.448 | 0.655 |
| Non-anxiety-depression subgroup | 4.2 ± 1.7 | 4.4 ± 1.9 | t = 0.588 | 0.558 |
| HADS-D scorec | ||||
| Anxiety-depression subgroup | 9.9 ± 2.2 | 9.7 ± 2.4 | t = 0.409 | 0.683 |
| Non-anxiety-depression subgroup | 3.8 ± 1.5 | 4.0 ± 1.7 | t = 0.665 | 0.507 |
| Preoperative cognitive assessment | ||||
| Mini-Mental State Examination score | 27.8 ± 1.6 | 27.6 ± 1.7 | t = 0.929 | 0.354 |
| Anxiety-depression subgroup | 27.1 ± 1.8 | 27.3 ± 1.9 | t = 0.508 | 0.613 |
| Non-anxiety-depression subgroup | 28.2 ± 1.3 | 28.0 ± 1.5 | t = 0.768 | 0.444 |
| Montreal Cognitive Assessment score | 25.1 ± 2.3 | 24.9 ± 2.4 | t = 0.660 | 0.509 |
| Anxiety-depression subgroup | 24.2 ± 2.6 | 24.4 ± 2.4 | t = 0.375 | 0.709 |
| Non-anxiety-depression subgroup | 25.6 ± 2.0 | 25.4 ± 2.2 | t = 0.510 | 0.611 |
| Preoperative laboratory tests | ||||
| Hemoglobin (g/L) | 128.5 ± 16.3 | 130.2 ± 17.8 | t = 0.740 | 0.460 |
| Albumin (g/L) | 38.6 ± 4.2 | 39.1 ± 4.5 | t = 0.858 | 0.392 |
| Serum creatinine (μmol/L) | 78.3 ± 18.5 | 76.9 ± 19.2 | t = 0.549 | 0.584 |
| Fasting glucose (mmol/L) | 5.8 ± 1.2 | 5.9 ± 1.3 | t = 0.596 | 0.552 |
- Citation: Li H, Teng JL, Yuan L, Han L. Goal-directed fluid therapy and cognitive outcomes in elderly surgical patients with anxiety and depression. World J Psychiatry 2026; 16(7): 117251
- URL: https://www.wjgnet.com/2220-3206/full/v16/i7/117251.htm
- DOI: https://dx.doi.org/10.5498/wjp.117251